53c2adf7bf6b8ee66bf440ec8d243c2d5bddd32a
PCBP1.md
| ... | ... | @@ -1,3 +1,9 @@ |
| 1 | +--- |
|
| 2 | +bibliography: 'morinlab.bib' |
|
| 3 | +csl: 'NLM.csl' |
|
| 4 | +link-citations: true |
|
| 5 | +--- |
|
| 6 | + |
|
| 1 | 7 | # PCBP1 |
| 2 | 8 | |
| 3 | 9 | ## History |
| ... | ... | @@ -13,8 +19,8 @@ timeline |
| 13 | 19 | |Entity|Tier|Description | |
| 14 | 20 | |:------:|:----:|--------------------------| |
| 15 | 21 | ||2|relevance in PMBL/cHL/GZL not firmly established| |
| 16 | -| |1 |high-confidence BL gene | |
|
| 17 | -| |1 |high-confidence DLBCL gene| |
|
| 22 | +| |1 |high-confidence BL gene[@schmitzBurkittLymphomaPathogenesis2012] | |
|
| 23 | +| |1 |high-confidence DLBCL gene[@schmitzBurkittLymphomaPathogenesis2012]| |
|
| 18 | 24 | |
| 19 | 25 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
| 20 | 26 | |
| ... | ... | @@ -61,5 +67,4 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/P |
| 61 | 67 | <!-- ORIGIN: schmitzBurkittLymphomaPathogenesis2012 --> |
| 62 | 68 | <!-- BL: schmitzBurkittLymphomaPathogenesis2012 --> |
| 63 | 69 | |
| 64 | -## References |
|
| 65 | -1. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867 |
|
| 70 | +# References |